MOH — authorised 15 June 2005
- Marketing authorisation holder: PF PRISM CV
- Status: likely_approved
MOH authorised Tygacil on 15 June 2005
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 15 June 2005.
PF PRISM CV holds the Israeli marketing authorisation.